160 related articles for article (PubMed ID: 22362890)
1. Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion.
Ferro D; Franciosa P; Cangemi R; Carnevale R; Pignatelli P; Loffredo L; Perri L; Catasca E; Violi F
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):327-33. PubMed ID: 22362890
[TBL] [Abstract][Full Text] [Related]
2. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
3. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
[TBL] [Abstract][Full Text] [Related]
5. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation.
Cangemi R; Celestini A; Calvieri C; Carnevale R; Pastori D; Nocella C; Vicario T; Pignatelli P; Violi F
Heart; 2012 Jul; 98(14):1063-6. PubMed ID: 22628539
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
[TBL] [Abstract][Full Text] [Related]
9. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation.
Leftheriotis DI; Fountoulaki KT; Flevari PG; Parissis JT; Panou FK; Andreadou IT; Venetsanou KS; Iliodromitis EK; Kremastinos DT
Int J Cardiol; 2009 Jul; 135(3):361-9. PubMed ID: 18640731
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
[TBL] [Abstract][Full Text] [Related]
12. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.
Wazni O; Martin DO; Marrouche NF; Shaaraoui M; Chung MK; Almahameed S; Schweikert RA; Saliba WI; Natale A
Heart; 2005 Oct; 91(10):1303-5. PubMed ID: 15890767
[TBL] [Abstract][Full Text] [Related]
13. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
14. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.
Korantzopoulos P; Kolettis TM; Kountouris E; Dimitroula V; Karanikis P; Pappa E; Siogas K; Goudevenos JA
Int J Cardiol; 2005 Jul; 102(2):321-6. PubMed ID: 15982504
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
[TBL] [Abstract][Full Text] [Related]
16. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Smith P; Arnesen H
Am J Cardiol; 2007 Jun; 99(11):1544-8. PubMed ID: 17531578
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
[TBL] [Abstract][Full Text] [Related]
19. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
[TBL] [Abstract][Full Text] [Related]
20. Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.
Xia W; Yin Z; Li J; Song Y; Qu X
Pacing Clin Electrophysiol; 2009 Dec; 32(12):1562-6. PubMed ID: 19793367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]